This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Jason D Riley: Innovator in Hematoma Detection
Introduction
Jason D Riley is a notable inventor based in London, GB. He has made significant contributions to the field of medical technology, particularly in the detection of hematomas. His innovative approach combines advanced light-emitting techniques with real-time monitoring to enhance patient care.
Latest Patents
Jason D Riley holds a patent for a "Method for detecting hematoma, portable detection and discrimination device and related systems and apparatuses." This patent features methods, apparatus, and devices designed to detect a hematoma in the tissue of a patient. The method involves emitting near-infrared light continuously into the tissue from a non-stationary near-infrared light emitter. It also includes continuously monitoring the tissue using a non-stationary probe to detect reflected light. The emitted near-infrared light penetrates to two different depths, allowing for a more accurate assessment. A ratiometric analysis is applied to the reflected light to distinguish between normal tissue and tissue exhibiting blood accumulation.
Career Highlights
Jason D Riley is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work focuses on developing innovative solutions that improve diagnostic capabilities in medical settings.
Collaborations
He has collaborated with notable colleagues such as Franck Amyot and Amir H Gandjbakhche, contributing to advancements in medical technology and research.
Conclusion
Jason D Riley's work in hematoma detection exemplifies the intersection of innovation and healthcare. His contributions are paving the way for improved diagnostic methods that can significantly benefit patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
